Nykode Therapeutics
Clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies.
Launch date
Employees
Market cap
CAD299m
Enterprise valuation
CAD66m (Public information from Sep 2024)
Share price
NOK5.05 NYKD.OL
Company register number 990646066
Oslo Norway (HQ)
Authorizing premium user...